<DOC>
	<DOCNO>NCT01992250</DOCNO>
	<brief_summary>This study examine use cryoablation alternative surgery treatment early stage invasive breast cancer . The hypothesis cryoablation complete ablation destroy tumor select population woman may otherwise adequately treat surgery .</brief_summary>
	<brief_title>Cryoablation Small Breast Tumors Early Stage Breast Cancer</brief_title>
	<detailed_description>PURPOSE : To determine rate successful tumor ablation patient treat cryoablation endocrine therapy subset patient early stage breast cancer . OUTLINE : 1 . Core Biopsy ( Pre-Registration ) 2 . Magnetic Resonance Imaging ( Pre-Registration ) 3 . Tumor Cryoablation 4 . Core Biopsy ( Post-Cryoablation ) 5 . Magnetic Resonance Imaging ( Post-Cryoablation ) 6 . Postoperative Follow-up 7 . Evaluation outcome</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>1 . Age ≥ 50 2 . Unifocal primary invasive breast carcinoma diagnose core needle biopsy 3 . Maximum tumor size ≤1.5 cm great diameter 4 . Ultrasound visible lesion ( ) 5 . Clinically node negative , hormone receptor positive ( + ) . HER2 negative ( ) , &lt; 25 % intraductal component aggregate . 6 . Unilateral bilateral disease meeting study criteria 7 . Physical emotional ability undergo baseline followup breast MRIs serial breast cosmesis analysis 8 . Patient agrees receive 5 year minimum course endocrine therapy follow cryoablation control systemic disease 1 . Prior treatment ( e.g. , open surgical biopsy , lumpectomy ) index cancer 2 . Ductal carcinoma insitu microinvasions ( T1mic ) 3 . Multifocal multicentric invasive breast carcinoma 4 . Prior plan neoadjuvant systemic therapy breast cancer 5 . Tumor ≥25 % IDC component</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Cryoablation</keyword>
</DOC>